INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,000 | +200.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -60.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $5,000 | -28.6% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |